Cocrystal Pharma (COCP) Goodwill & Intangibles (2011 - 2022)

Cocrystal Pharma has reported Goodwill & Intangibles for 12 years, with the latest figure at $19.1 million in Q1 2022.

• Quarterly Goodwill & Intangibles changed 0.0% year-over-year to $19.1 million in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $19.1 million (changed 0.0% YoY) and the FY2021 annual result came in at $19.1 million, changed 0.0% from the prior year.
• Goodwill & Intangibles was little changed at $19.1 million in Q1 2022 per COCP's latest filing, from $19.1 million in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $65.2 million in Q1 2018 and troughed at $19.1 million in Q4 2019.
• A 5-year average of $38.1 million and a median of $19.1 million in 2019 frame the typical range for Goodwill & Intangibles.
• The sharpest annual moves came in 2018 and 2019: Goodwill & Intangibles changed 0.0% in 2018, then sank 70.72% in 2019.
• Over 5 years, Goodwill & Intangibles stood at $65.2 million in 2018, then tumbled by 70.72% to $19.1 million in 2019, then changed by 0.0% to $19.1 million in 2020, then changed by 0.0% to $19.1 million in 2021, then changed by 0.0% to $19.1 million in 2022.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $19.1 million, $19.1 million, and $19.1 million for Q1 2022, Q4 2021, and Q3 2021 respectively.